New Delhi: The US Food and Drug Administration (FDA) has raised an alarm about premature battery depletion in certain Medtronic pacemaker models, which could lead to devices losing power quickly and triggering a medical emergency.
The models affected by the battery issue include Azure, Astra, Percepta, Serena and Solara, according to the US regulator. The FDA, in its safety communication, alerted healthcare providers and patients about the batteries in certain Medtronic implantable pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps), which can drain faster than expected, without any warning.
